Role of CaMKII in cardiac arrhythmias

Thomas J Hund1, Peter J Mohler2

  • 1The Dorothy M. Davis Heart & Lung Research Institute, OH; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH; Department of Biomedical Engineering, The Ohio State University College of Engineering, Columbus, OH.

Insights

Calcium/calmodulin-dependent protein kinase II (CaMKII) is crucial for cardiovascular signaling. Targeting CaMKII, particularly its association with late sodium current, may offer new strategies for preventing cardiac arrhythmias.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein phosphorylation regulates vital cardiovascular functions, including excitation-contraction coupling and metabolism.
  • Calcium/calmodulin-dependent protein kinase II (CaMKII) plays a critical role in cardiac physiology, with its dysfunction linked to heart failure and arrhythmia.
  • Despite extensive research, targeting CaMKII for antiarrhythmic therapies has faced challenges due to specificity and numerous downstream targets.

Purpose of the Study:

  • To review current CaMKII-regulated pathways in the cardiovascular system.
  • To identify potential upstream regulatory mechanisms and downstream targets for modulating CaMKII signaling.
  • To explore the potential of CaMKII-associated late Na(+) current as a novel therapeutic target for cardiac arrhythmia.

Main Methods:

  • Literature review of CaMKII signaling in cardiovascular disease.
  • Analysis of CaMKII's role in excitation-contraction coupling, metabolism, and electrical activity.
  • Investigation of CaMKII's association with ion channel function, particularly the late Na(+) current.

Main Results:

  • CaMKII is implicated in multiple cardiac processes, and its dysregulation contributes to cardiovascular pathologies.
  • Previous attempts to target CaMKII for antiarrhythmic effects have been hindered by lack of specificity and complexity of its targets.
  • The CaMKII-associated late Na(+) current presents a promising, specific target for novel antiarrhythmic strategies.

Conclusions:

  • CaMKII is a key regulator of cardiovascular function, and its aberrant activity contributes to disease.
  • Understanding CaMKII's upstream and downstream effectors is crucial for developing effective cardiovascular therapies.
  • Targeting the CaMKII-associated late Na(+) current offers a potential new avenue for treating cardiac arrhythmias.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.6K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
7.4K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
11.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
3.0K